MERS-CoV papain-like protease has deISGylating and deubiquitinating activities

Virology

Volumn 450-451, Issue , 2014, Pages 64-70

  Mielech, Anna M ^a   Kilianski, Andy ^a   Baez Santos, Yahira M ^b   Mesecar, Andrew D ^b   Baker, Susan C ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

DeISGylating activity; DUB activity; ISG15; MERS CoV; PLpro; Ubiquitin

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS PAPAIN LIKE PROTEASES; NONSTRUCTURAL PROTEIN 3; PAPAIN; RANTES; UNCLASSIFIED DRUG;

ARTICLE; CORONAVIRUS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SARS CORONAVIRUS; UBIQUITINATION; UPREGULATION; VIRUS REPLICATION;

DEISGYLATING ACTIVITY; DUB ACTIVITY; ISG15; MERS-COV; PLPRO; UBIQUITIN;

AMINO ACID SEQUENCE; CELL LINE; CORONAVIRIDAE; CORONAVIRIDAE INFECTIONS; CYTOKINES; GLYCOSYLATION; HUMANS; MOLECULAR SEQUENCE DATA; PAPAIN; PROTEIN STRUCTURE, TERTIARY; SARS VIRUS; UBIQUITINATION; UBIQUITINS; VIRAL PROTEINS;

EID: 84890863276     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.11.040     Document Type: Article

References (41)

1. Assiri A., McGeer A., Perl T.M., Price C.S., Al Rabeeah A.A., Cummings D.A., et al. Hospital outbreak of middle east respiratory syndrome coronavirus. N. Engl. J. Med. 2013, 369:407-416.
2. Barretto N., Jukneliene D., Ratia K., Chen Z., Mesecar A.D., Baker S.C. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J. Virol. 2005, 79(24):15189-15198.
3. Clementz M.A., Chen Z., Banach B.S., Wang Y., Sun L., Ratia K., et al. Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J. Virol. 2010, 84(9):4619-4629.
4. Chen Z., Wang Y., Ratia K., Mesecar A.D., Wilkinson K.D., Baker S.C. Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63. J. Virol. 2007, 81(11):6007-6018.
5. Drosten C., Seilmaier M., Corman V.M., Hartmann W., Scheible G., Sack S., et al. Clinical features and virological analysis of a case of middle east respiratory syndrome coronavirus infection. Lancet Infect. Dis. 2013, 13(9):745-751.
6. Devaraj S.G., Wang N., Chen Z., Chen Z., Tseng M., Barretto N., et al. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J. Biol. Chem. 2007, 282(44):32208-32221.
7. Frieman M., Ratia K., Johnston R.E., Mesecar A.D., Baric R.S. Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling. J. Virol. 2009, 83(13):6689-6705.
8. Frias-Staheli N., Giannakopoulos N.V., Kikkert M., Taylor S.L., Bridgen A., Paragas J., et al. Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2007, 2(6):404-416.
9. Guery B., Poissy J., El Mansouf L., Sejourne C., Ettahar N., Lemaire X., et al. Clinical features and viral diagnosis of two cases of infection with middle east respiratory syndrome coronavirus: a report of nosocomial transmission. Lancet 2013, 381(9885):2265-2272.
10. Josset L., Menachery V.D., Gralinski L.E., Agnihothram S., Sova P., Carter V.S., et al. Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. mBio 2013, 4(3), 10.1128/mBio.00165-13.
11. Kilianski A., Mielech A., Deng X., Baker S.C. Assessing activity and inhibition of MERS-CoV papain-like and 3C-like proteases using luciferase-based biosensors. J. Virol. 2013, 87(21):11955-11962.
12. Kopecky-Bromberg S., Martinez-Sobrido L., Frieman M., Baric R., Palese P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J. Virol. 2007, 81(2):548-557.
13. Kamitani W., Huang C., Narayanan K., Lokugamage K., Makino S. A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein. Nat. Struct. Mol. Biol. 2009, 16(11):1134-1140.
14. Lau S.K., Woo P.C., Li K.S., Huang Y., Tsoi H.W., Wong B.H., et al. Severe acute respiratory syndrome coronavirus-like virus in chinese horseshoe bats. Proc. Natl. Acad. Sci. USA 2005, 102(39):14040-14045.
15. Lindner H.A., Fotouhi-Ardakani N., Lytvyn V., Lachance P., Sulea T., Menard R. The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme. J. Virol. 2005, 79(24):15199-15208.
16. Lindner H.A., Lytvyn V., Qi H., Lachance P., Ziomek E., Menard R. Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease. Arch. Biochem. Biophys. 2007, 466(1):8-14.
17. Memish Z., Mishra N., Olival K., Fagbo S., Kapoor V., Epstein J. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg. Infect. Dis. 2013, 19(11):1819-1823.
18. Niemeyer D., Zillinger T., Muth D., Zielecki F., Horvath G., Suliman T., et al. Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J. Virol. 2013, (Epub ahead of print). 10.1128/JVI.01845-13.
19. Perlman S., Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 2009, 7(6):439-450.
20. Qian Z., Travanty E., Oko L., Edeen K., Berglund A., Wang J., et al. Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. Am. J. Respir. Cell Mol. Biol. 2013, 48(6):742-748.
21. Reusken C.B., Haagmans B.L., Müller M.A., Gutierrez C., Godeke G., Meyer B., et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect. Dis. 2013, 13(10):859-866.
22. Rockx B., Sheahan T., Donaldson E., Harkema J., Sims A., Heise M., et al. Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice. J. Virol. 2007, 81(14):7410-7423.
23. Ratia K., Saikatendu K.S., Santarsiero B.D., Barretto N., Baker S.C., Stevens R.C., et al. Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme. Proc. Natl. Acad. Sci. USA 2006, 103(15):5717-5722.
24. Rothenfusser S., Goutagny N., DiPerna G., Gong M., Monks B.G., Schoenemeyer A., et al. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J. Immunol. 2005, 175(8):5260-5268.
25. Ratia K., Pegan S., Takayama J., Sleeman K., Coughlin M., Baliji S., et al. A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proc. Natl. Acad. Sci. USA 2008, 105(42):16119-16124.
26. Snijder E.J., van der Meer Y., Zevenhoven-Dobbe J., Onderwater J.J., van der Meulen J., Koerten H.K., et al. Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J. Virol. 2006, 80(12):5927-5940.
27. Sulea T., Lindner H.A., Purisima E.O., Menard R. Deubiquitination, a new function of the severe acute respiratory syndrome coronavirus papain-like protease?. J. Virol. 2005, 79(7):4550-4551.
28. Spiegel M., Weber F. Inhibition of cytokine gene expression and induction of chemokine genes in non-lymphatic cells infected with SARS coronavirus. Virol. J. 2006, 3:17.
29. Sun Z., Chen Z., Lawson S.R., Fang Y. The cysteine protease domain of porcine reproductive and respiratory syndrome virus nonstructural protein 2 possesses deubiquitinating and interferon antagonism functions. J. Virol. 2010, 84(15):7832-7846.
30. Sun Z., Li Y., Ransburgh R., Snijder E.J., Fang Y. Nonstructural protein 2 of porcine reproductive and respiratory syndrome virus inhibits the antiviral function of interferon-stimulated gene 15. J. Virol. 2012, 86(7):3839-3850.
31. Totura A.L., Baric R.S. SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon. Curr. Opin. Virol. 2012, 2(3):264-275.
32. van Boheemen S., de Graaf M., Lauber C., Bestebroer T.M., Raj V.S., Zaki A.M., et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio 2012, 3(6):10.
33. van Kasteren P.B., Bailey-Elkin B.A., James T.W., Ninaber D.K., Beugeling C., Khajehpour M., et al. Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells. Proc. Natl. Acad. Sci. USA 2013, 110(9):E838-E847.
34. van Kasteren P.B., Beugeling C., Ninaber D.K., Frias-Staheli N., van Boheemen S., Garcia-Sastre A., et al. Arterivirus and nairovirus ovarian tumor domain-containing deubiquitinases target activated RIG-I to control innate immune signaling. J. Virol. 2012, 86(2):773-785.
35. Wong C., Lam C., Wu A., Ip W., Lee N., Chan I., et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin. Exp. Immunol. 2004, 136(1):95-103.
36. Xing Y., Chen J., Tu J., Zhang B., Chen X., Shi H., et al. The papain-like protease of porcine epidemic diarrhea virus negatively regulates type I interferon pathway by acting as a viral deubiquitinase. J. Gen. Virol. 2013, 94(Pt 7):1554-1567.
37. Yoshikawa T., Hill T., Yoshikawa N., Popov V., Galindo C., Garner H., et al. Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection. PLoS One 2010, 5(1):e8729.
38. Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 2012, 367(19):1814-1820.
39. Zheng D., Chen G., Guo B., Cheng G., Tang H. PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production. Cell Res. 2008, 18(11):1105-1113.
40. Zust R., Cervantes-Barragan L., Habjan M., Maier R., Neuman B.W., Ziebuhr J., et al. Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat. Immunol. 2011, 12(2):137-143.
41. Zhao L., Jha B., Wu A., Elliott R., Ziebuhr J., Gorbalenya A., et al. Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. Cell Host Microbe 2012, 11(6):607-616.